EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACCINE PRODUCTI

File: 970107_sep96_decls48_0001.txt
Page: 0001
Total Pages: 3

Subject: EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACCINE PRODUCTI    

Unit: OTSG        

Parent Organization: HSC         

Box  ID: BX003201

Folder Title: EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACCINE - 1                                         

Document Number:          1

Folder Seq  #:         43


                                    crr[li I
                                            L I     UNCLASSIFIED

                          THE ASSISTANT SECRETARY OF DEFENSE

                                WASHINGTON, D. C. 20301-1200



                                                        5 OCT MO
   HEALTH AFFAIRS




         MEMORANDUM FOR SECRETARY OF THE ARMY

         SUBJECT: Expansion of Industrial Base for Biological Vaccine
                  Production @


                   on October 3, 1990, the Secretary of Defense directed
         that I take the necessary actions, on a priority basis, to
         acquire a second source to produce biological vaccines to protect
         against anthrax and botulinum toxin.

                   To accomplish this in an accelerated timeframe, the
         Secretary suggested that I charter a  Tri-Service Task Force to
         address this issue. The mission of the Task Force will be to:          C:3

                  1. Perform an investigation of the industrial base
         capability.

                  2. Develop short-term options and recommendations    for
         increasing vaccine production.

                  3. Develop long-term options and recommendations for
         increasing vaccine production.                                         00

              (U) Achieving these goals by December 1990 will require the@-
         cooperation of all the Services. The Task Force will be under      L@
         the direction of Dr. Peter Collis, the Deputy Assistant Secretary'@.
         of Defense for Medical Readiness. I request that the Army
         Surgeon General establish executive management authority for the
         Task Force by assigning the U.S. Army Medical Research and
         Development Command as lead agent. The technical nature of the
         assignment necessitates assembling specific personnel with the
         unique expertise to perform the required tasks.

                   The Task Force is to develop and submit for approval
      plans to accomplish each of the above tasks for both the anthrax
         vaccine and the botulinum toxin vaccine. These plans are to
         highlight the specific actions to be taken along with associated
         DECLASSIFIED
         ON: 23 DEC 96
                         Yl(t!?AMkQ4UnER SEC 3.4 EO 12958
         Declassify on: OADR
                                              m I r@R DFI LE iP
                                              FICHE

                                                                           oq CIO?


                                           UNCLASSIFIED

Document 3 f:/Week-36/BX003201/EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACCINE - 1/expansion of industrial base for biological vacc:01029715473849
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003201
Unit = OTSG
Parent Organization = HSC
Folder Title = EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACCINE - 1
Folder Seq # = 43
Subject = EXPANSION OF INDUSTRIAL BASE FOR BIOLOGICAL VACC
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997